Joel C. Johnson

• Represented health care company in its acquisition of senior care and other provider organizations.
• Represented multinational company in its carve out divestiture of a complex contact center business.
• Represented public ethanol company in its $68.8 million acquisition of operating ethanol plants.
• Represented Canadian corporation in $87 million acquisition of assets based in the U.S.
• Represented a U.S. software company in its $15 million acquisition of a U.K.-based digital rights management company.
• Represented expense management company in the $165 million sale of equity interests.

Financing

• Represented medical device company in $30 million bridge financing and private placement of equity securities.
• Represented hedge fund in $7 million subordinated debt financing secured by assets in the United States, Canada, United Kingdom, and France.
• Represented renewable energy company in $130 million senior and subordinated debt refinancing.
• Represented Native American tribe in issuance of $320 million of senior notes for the construction of a casino near Seattle, Washington.

Other Matters

• Represented national exchange in the creation of a new futures and options market.
• Represented private companies in hostile member and shareholder buyouts.
• Represented multinational corporation in negotiation, drafting, and implementation of critical application services and business process outsourcing agreements.

• Represented national financial services company in an underwritten public offering of $200 million of senior notes, including registration of securities on the New York Stock Exchange.
• Represented national financial services company in an underwritten public offering of $300 million of senior notes.
• Represented company in shelf registration of common stock, preferred stock, and senior and subordinated debt securities.
• Represented company in an underwritten public offering of an aggregate of $800 million of notes.
• Represented company in an underwritten public offering of $200 million of common stock.